Dário Rosa Mondini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dário Rosa Mondini has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Heitor Siqueira Ribeiro
Faculty of Health Sciences, University of Brasilia, Brasilia, Brazil
8 shared publications - Daiana Cristine Bündchen
Department of Physiotherapy, Federal University of Santa Catarina, Araranguá, Brazil
7 shared publications - Henrique dos Santos Disessa
Department of Physical Education, School of Sciences, Sao Paulo State University, UNESP, Bauru, Brazil
7 shared publications - Maristela Böhlke
Postgraduate Program in Health and Behavior, Catholic University of Pelotas, Pelotas, Brazil
7 shared publications - Maryanne Zilli Canedo Silva
Sao Paulo State University (UNESP) - Botucatu Medicine School, Botucatu, Brazil
7 shared publications - Maycon Moura Reboredo
School of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Brazil
7 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Elsevier in Journal of Renal Nutrition
Is Exercising During Dialysis Enough? Rethinking Approaches to be Physically Active
- 9 November 2026
- Published by Elsevier in Journal of Renal Nutrition
Open AccessIs Exercising During Dialysis Enough? Rethinking Approaches to be Physically Active
- Open Access
- 26 October 2026
- Published by Sociedade Brasileira de Atividade Física e Saúde in Revista Brasileira de Atividade Física & Saúde
- Vol. 31, 1-15
Atividade física de deslocamento no Brasil: uma análise de tendências temporais com dados do Vigitel
Introdução: A atividade física (AF) de deslocamento em meio urbano pode apresentar benefícios para a saúde, sustentabilidade e no direito à cidade, porém, ainda carecem de estudos que investiguem as iniquidades associadas. Considerando as desigualdades entre as macrorregiões brasileiras, faz-se necessário compreender como fatores sociodemográficos influenciam a prática de AF de deslocamento ao longo do tempo. Objetivos: Avaliar a tendência temporal da AF de deslocamento nas macrorregiões do Brasil e sua potencial associação com as variáveis sexo, faixa etária, escolaridade e raça/cor. Métodos: Foram utilizados dados do inquérito telefônico Vigitel, compreendendo 623.193 adultos (≥18 anos) residentes das capitais brasileiras e do Distrito Federal, entre 2009 e 2023. Foram classificados como ativos os indivíduos que atingiram ≥ 150 minutos/semana de AF de deslocamento. Para avaliar as variáveis de interesse, foram aplicados modelos de regressão logística com formas funcionais não-lineares, com nós posicionados nos anos de 2015, 2020 e 2021. Resultados: A proporção de indivíduos ativos no deslocamento diminuiu de 17,9% (IC 95%: 17,2; 18,7) em 2009 para 12,5% (IC 95%: 11,5; 13,6) em 2023. Todas as macrorregiões apresentaram tendência de redução, com a menor prevalência no Centro-Oeste e a maior no Sudeste. Mulheres, pessoas idosas, brancas e com idade maior (12 ou mais anos) e menor (0-4 anos) escolaridade apresentaram menores níveis de AF de deslocamento durante toda a série. Conclusão: Diante da tendência de declínio de AF de deslocamento, a qual está diferentemente relacionada a fatores sociodemográficos, reforça-se a necessidade de políticas que ampliem o seu acesso como escolha, considerando os seus determinantes de forma mais abrangente.
- 26 October 2026
- Published by Sociedade Brasileira de Atividade Física e Saúde in Revista Brasileira de Atividade Física & Saúde
- Vol. 31, 1-15
Open AccessAtividade física de deslocamento no Brasil: uma análise de tendências temporais com dados do Vigitel
Introdução: A atividade física (AF) de deslocamento em meio urbano pode apresentar benefícios para a saúde, sustentabilidade e no direito à cidade, porém, ainda carecem de estudos que investiguem as iniquidades associadas. Considerando as desigualdades entre as macrorregiões brasileiras, faz-se necessário compreender como fatores sociodemográficos influenciam a prática de AF de deslocamento ao longo do tempo. Objetivos: Avaliar a tendência temporal da AF de deslocamento nas macrorregiões do Brasil e sua potencial associação com as variáveis sexo, faixa etária, escolaridade e raça/cor. Métodos: Foram utilizados dados do inquérito telefônico Vigitel, compreendendo 623.193 adultos (≥18 anos) residentes das capitais brasileiras e do Distrito Federal, entre 2009 e 2023. Foram classificados como ativos os indivíduos que atingiram ≥ 150 minutos/semana de AF de deslocamento. Para avaliar as variáveis de interesse, foram aplicados modelos de regressão logística com formas funcionais não-lineares, com nós posicionados nos anos de 2015, 2020 e 2021. Resultados: A proporção de indivíduos ativos no deslocamento diminuiu de 17,9% (IC 95%: 17,2; 18,7) em 2009 para 12,5% (IC 95%: 11,5; 13,6) em 2023. Todas as macrorregiões apresentaram tendência de redução, com a menor prevalência no Centro-Oeste e a maior no Sudeste. Mulheres, pessoas idosas, brancas e com idade maior (12 ou mais anos) e menor (0-4 anos) escolaridade apresentaram menores níveis de AF de deslocamento durante toda a série. Conclusão: Diante da tendência de declínio de AF de deslocamento, a qual está diferentemente relacionada a fatores sociodemográficos, reforça-se a necessidade de políticas que ampliem o seu acesso como escolha, considerando os seus determinantes de forma mais abrangente.
- Open Access
- 21 March 2026
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 36 (4) , 623-630
Severity of Cognitive Dysfunction Associates With Sarcopenia in Patients on Hemodialysis: Findings From the SARC-HD Study
- 21 March 2026
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 36 (4) , 623-630
Open AccessSeverity of Cognitive Dysfunction Associates With Sarcopenia in Patients on Hemodialysis: Findings From the SARC-HD Study
- Open Access
- 16 January 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0339795
Skeletal muscle-kidney crosstalk in a cohort of critical illness survivors
Background: The skeletal muscles and kidneys are frequently affected during critical illness; however, their crosstalk remains poorly explored, especially in the long-term evolution. Therefore, we investigated the crosstalk between skeletal muscle and kidney function in COVID-19 survivors. Methods: A cross-sectional analysis of a prospective cohort study with s urvivors of moderate to severe COVID-19 hospitalization. Skeletal muscle assessments included handgrip strength, calf circumference, ultrasound-measured quadriceps thickness, and gait speed test. Sarcopenia was diagnosed by modified EWGSOP2 (low handgrip strength plus low ultrasound-measured quadriceps thickness). Kidney function was assessed by estimated glomerular filtration rate (eGFR), urinary albumin-to-creatinine ratio (UACR), and urine sediment analysis. Abnormal kidney function was defined as an eGFR < 60 mL/min/1.73m 2 , albuminuria (≥30 mg/g), and/or leukocyturia or hematuria. Results: A total of 734 survivors (46% female, 43% ≥ 60 years, 35% with diabetes) were assessed 7 ± 2 months post-hospital discharge. Sarcopenia was diagnosed in 21.4% of the cohort. Positive significant associations with eGFR were observed for calf circumference (β = 0.42 ml/min/1.73m 2 , 95%CI: 0.06 to 0.78) and thicknesses (mm) of rectus femoris (β = 0.47, 95%CI: 0.01 to 0.94) and vastus intermedius (β = 0.55, 95%CI: 0.14 to 0.96). None of the skeletal muscle parameters were associated with UACR (mg/g). Survivors with sarcopenia had lower eGFR (‒5.8 ml/min/1.73m 2 , 95%CI: ‒10.8 to ‒0.9), but similar frequencies of low eGFR (24% vs . 18%; p = 0.137), albuminuria (27% vs . 31%; p = 0.434) and abnormal urine sediment (17% vs . 22%; p = 0.217) as compared to those without sarcopenia. Sarcopenia was not associated with higher odds of low eGFR, albuminuria, or abnormal urine sediment. Conclusions: In survivors of moderate to severe COVID-19 hospitalization, skeletal muscle mass was associated with eGFR, whereas sarcopenia per se was not independently associated with poor kidney function. These findings suggest the existence of a skeletal muscle-kidney crosstalk in this population.
- 16 January 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0339795
Open AccessSkeletal muscle-kidney crosstalk in a cohort of critical illness survivors
Background: The skeletal muscles and kidneys are frequently affected during critical illness; however, their crosstalk remains poorly explored, especially in the long-term evolution. Therefore, we investigated the crosstalk between skeletal muscle and kidney function in COVID-19 survivors. Methods: A cross-sectional analysis of a prospective cohort study with s urvivors of moderate to severe COVID-19 hospitalization. Skeletal muscle assessments included handgrip strength, calf circumference, ultrasound-measured quadriceps thickness, and gait speed test. Sarcopenia was diagnosed by modified EWGSOP2 (low handgrip strength plus low ultrasound-measured quadriceps thickness). Kidney function was assessed by estimated glomerular filtration rate (eGFR), urinary albumin-to-creatinine ratio (UACR), and urine sediment analysis. Abnormal kidney function was defined as an eGFR < 60 mL/min/1.73m 2 , albuminuria (≥30 mg/g), and/or leukocyturia or hematuria. Results: A total of 734 survivors (46% female, 43% ≥ 60 years, 35% with diabetes) were assessed 7 ± 2 months post-hospital discharge. Sarcopenia was diagnosed in 21.4% of the cohort. Positive significant associations with eGFR were observed for calf circumference (β = 0.42 ml/min/1.73m 2 , 95%CI: 0.06 to 0.78) and thicknesses (mm) of rectus femoris (β = 0.47, 95%CI: 0.01 to 0.94) and vastus intermedius (β = 0.55, 95%CI: 0.14 to 0.96). None of the skeletal muscle parameters were associated with UACR (mg/g). Survivors with sarcopenia had lower eGFR (‒5.8 ml/min/1.73m 2 , 95%CI: ‒10.8 to ‒0.9), but similar frequencies of low eGFR (24% vs . 18%; p = 0.137), albuminuria (27% vs . 31%; p = 0.434) and abnormal urine sediment (17% vs . 22%; p = 0.217) as compared to those without sarcopenia. Sarcopenia was not associated with higher odds of low eGFR, albuminuria, or abnormal urine sediment. Conclusions: In survivors of moderate to severe COVID-19 hospitalization, skeletal muscle mass was associated with eGFR, whereas sarcopenia per se was not independently associated with poor kidney function. These findings suggest the existence of a skeletal muscle-kidney crosstalk in this population.
- Open Access
- 18 June 2025
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 37 (1) , 1-7
Polypharmacy and sarcopenia in patients on hemodialysis: results from the SARC-HD study
Background We investigated the association between polypharmacy and sarcopenia in patients on hemodialysis. Methods Cross-sectional data from the SARC-HD study were analyzed. Patients were classified according to the number of prescribed medications as no polypharmacy (0–4), polypharmacy (5–9), and hyperpolypharmacy (≥ 10). Sarcopenia was diagnosed and staged according to the adapted EWGSOP2 consensus. Results 955 patients (48% ≥ 60 years, 61% male) were analyzed. Polypharmacy and hyperpolypharmacy were observed in 50% and 26% of patients, respectively. Patients with hyperpolypharmacy had poorer physical function compared to the no polypharmacy group. Low muscle strength was found in 45%, while sarcopenia (confirmed and severe stages) in 21% of the cohort. Patients in the polypharmacy groups had higher prevalence of low muscle strength, but similar sarcopenia rates to those in the no polypharmacy group. Only hyperpolypharmacy was independently associated with low muscle strength (64% higher adjusted odds, 95% CI 1.10–2.46), whereas no significant associations were observed with sarcopenia. Also, each addition of two medications was independently associated with 10% higher adjusted odds (95% CI 1.02–1.20) of low muscle strength. Conclusions In patients on hemodialysis, the number of medications and hyperpolypharmacy were independently associated with low muscle strength, but not with sarcopenia per se.
- 18 June 2025
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 37 (1) , 1-7
Open AccessPolypharmacy and sarcopenia in patients on hemodialysis: results from the SARC-HD study
Background We investigated the association between polypharmacy and sarcopenia in patients on hemodialysis. Methods Cross-sectional data from the SARC-HD study were analyzed. Patients were classified according to the number of prescribed medications as no polypharmacy (0–4), polypharmacy (5–9), and hyperpolypharmacy (≥ 10). Sarcopenia was diagnosed and staged according to the adapted EWGSOP2 consensus. Results 955 patients (48% ≥ 60 years, 61% male) were analyzed. Polypharmacy and hyperpolypharmacy were observed in 50% and 26% of patients, respectively. Patients with hyperpolypharmacy had poorer physical function compared to the no polypharmacy group. Low muscle strength was found in 45%, while sarcopenia (confirmed and severe stages) in 21% of the cohort. Patients in the polypharmacy groups had higher prevalence of low muscle strength, but similar sarcopenia rates to those in the no polypharmacy group. Only hyperpolypharmacy was independently associated with low muscle strength (64% higher adjusted odds, 95% CI 1.10–2.46), whereas no significant associations were observed with sarcopenia. Also, each addition of two medications was independently associated with 10% higher adjusted odds (95% CI 1.02–1.20) of low muscle strength. Conclusions In patients on hemodialysis, the number of medications and hyperpolypharmacy were independently associated with low muscle strength, but not with sarcopenia per se.
- Open Access
- 1 March 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 47 (1) , e20240009
Pesquisa multicêntrica em centros de diálise no Brasil: recrutamento e implementação do estudo SARC-HD
Introdução: Pesquisa multicêntrica em centros de diálise brasileiros são escassas. Descrevemos as fases de recrutamento e implementação do estudo SARC-HD, visando investigar a sarcopenia e seu impacto em desfechos clínicos adversos.
- 1 March 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 47 (1) , e20240009
Open AccessPesquisa multicêntrica em centros de diálise no Brasil: recrutamento e implementação do estudo SARC-HD
Introdução: Pesquisa multicêntrica em centros de diálise brasileiros são escassas. Descrevemos as fases de recrutamento e implementação do estudo SARC-HD, visando investigar a sarcopenia e seu impacto em desfechos clínicos adversos.
- Open Access
- 1 March 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 47 (1) , e20240009
Multicenter research in dialysis centers in Brazil: recruitment and implementation of the SARC-HD study
Introduction: Multicenter research initiatives in Brazilian dialysis centers are scarce. We described the recruitment and implementation phases of the SARC-HD study, aimed at investigating sarcopenia and its impact on adverse clinical outcomes.
- 1 March 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 47 (1) , e20240009
Open AccessMulticenter research in dialysis centers in Brazil: recruitment and implementation of the SARC-HD study
Introduction: Multicenter research initiatives in Brazilian dialysis centers are scarce. We described the recruitment and implementation phases of the SARC-HD study, aimed at investigating sarcopenia and its impact on adverse clinical outcomes.
- 16 October 2024
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 40 (5) , 987-996
Reference values for handgrip strength, five times sit-to-stand and gait speed in patients on hemodialysis
Low levels of muscle strength and function predict adverse clinical outcomes in patients on hemodialysis; however, reference values remain lacking. We described reference values for handgrip strength, five times sit-to-stand (STS-5), and 4-m gait speed in a large-scale sample in patients on hemodialysis. Baseline data from the SARCopenia trajectories and associations with adverse clinical outcomes in patients on HemoDialysis (SARC-HD) study were analyzed. Muscle strength was evaluated using handgrip strength and the STS-5, whereas physical performance was evaluated using usual 4-m gait speed before a midweek dialysis session. Sex- and age-specific smoothed reference curves for each test at the 3rd, 15th, 50th, 85th, and 97th percentiles were constructed using generalized additive models for location shape and scale. Comparisons between sex and age were also performed. Data from 1004 patients (39% female; 19 to 96 years; 49% ≥ 60 years) were analyzed. Declines in muscle strength and physical performance were observed with advancing age in both sexes. However, among males, muscle strength and performance were similar between 18 and 49 years of age. Males exhibited substantially greater performance in handgrip strength (10.3 kg, 95% confidence interval (CI) 9.1 to 11.4) and 4-m gait speed (–0.10 seconds, 95% CI: –0.14 to –0.05) compared to females. Older patients, independent of sex, exhibited poorer performance on most tests. Lower handgrip strength in the arm with arteriovenous fistula was observed in both sexes (males –2.3 kg, 95% CI: –2.8 to –1.7; and females –2.1 kg, 95% CI: –2.6 to –1.6). Reference values obtained in this study may be used in clinical and research settings to identify patients on hemodialysis with low physical function according to sex and age. Future studies should test these reference values as potential predictors of adverse clinical outcomes.
- 16 October 2024
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 40 (5) , 987-996
Reference values for handgrip strength, five times sit-to-stand and gait speed in patients on hemodialysis
Low levels of muscle strength and function predict adverse clinical outcomes in patients on hemodialysis; however, reference values remain lacking. We described reference values for handgrip strength, five times sit-to-stand (STS-5), and 4-m gait speed in a large-scale sample in patients on hemodialysis. Baseline data from the SARCopenia trajectories and associations with adverse clinical outcomes in patients on HemoDialysis (SARC-HD) study were analyzed. Muscle strength was evaluated using handgrip strength and the STS-5, whereas physical performance was evaluated using usual 4-m gait speed before a midweek dialysis session. Sex- and age-specific smoothed reference curves for each test at the 3rd, 15th, 50th, 85th, and 97th percentiles were constructed using generalized additive models for location shape and scale. Comparisons between sex and age were also performed. Data from 1004 patients (39% female; 19 to 96 years; 49% ≥ 60 years) were analyzed. Declines in muscle strength and physical performance were observed with advancing age in both sexes. However, among males, muscle strength and performance were similar between 18 and 49 years of age. Males exhibited substantially greater performance in handgrip strength (10.3 kg, 95% confidence interval (CI) 9.1 to 11.4) and 4-m gait speed (–0.10 seconds, 95% CI: –0.14 to –0.05) compared to females. Older patients, independent of sex, exhibited poorer performance on most tests. Lower handgrip strength in the arm with arteriovenous fistula was observed in both sexes (males –2.3 kg, 95% CI: –2.8 to –1.7; and females –2.1 kg, 95% CI: –2.6 to –1.6). Reference values obtained in this study may be used in clinical and research settings to identify patients on hemodialysis with low physical function according to sex and age. Future studies should test these reference values as potential predictors of adverse clinical outcomes.
- 15 October 2024
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 39 (6) , 1441-1451
Agreement between the EWGSOP2 and SDOC consensuses for sarcopenia in patients receiving hemodialysis: Findings of a cross sectional analysis from the SARC‐HD study
Background: Differences in definitions and operational diagnoses for sarcopenia create difficulties in understanding the epidemiology of the disease. We examined the prevalences of sarcopenia using the revised European Working Group on Sarcopenia in Older People (EWGSOP2) and the Sarcopenia Definitions and Outcomes Consortium (SDOC) consensuses and analyzed their level of agreement in patients receiving hemodialysis.Methods: Data from the SARCopenia trajectories and associations with clinical outcomes in patients receiving hemodialysis (SARC‐HD) multicenter study in Brazil were analyzed. Muscle strength was assessed using handgrip strength, muscle mass by calf circumference, and physical performance by the 4‐m gait speed test. Sarcopenia was diagnosed according to both the EWGSOP2 (low muscle strength plus low muscle mass) and the SDOC (low muscle strength plus low physical performance). The Cohen kappa statistic was used to determine the level of agreement between the consensuses.Results: 838 patients (57.8 ± 15.0 years; 61% men) from 19 dialysis units were included. We found similar prevalences of sarcopenia between the consensuses (EWGSOP2, n = 128, 15.3%; SDOC, n = 105, 12.5%) but with weak agreement (50 of 233 patients, 21.5%; κ = 0.34, 95% CI 0.25–0.43). Agreement was also weak within age categories (≥60 years, κ = 0.34; P < 0.001). Of the 51 patients diagnosed by the EWGSOP2 criterion as having severe sarcopenia, all but 1 (98.0%) met the SDOC criterion for sarcopenia (κ = 0.61, 95% CI 0.52–0.70). Low muscle strength was more frequently diagnosed using the SDOC than with the EWGSOP2 (52.3% vs 25.9%).Conclusion: We found a weak agreement between the EWGSOP2 and SDOC consensuses for the diagnosis of sarcopenia in patients receiving hemodialysis. Although still weak, agreement was marginally better for older patients. These findings highlight the importance of a global and standardized conceptual diagnosis of sarcopenia.
- 15 October 2024
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 39 (6) , 1441-1451
Agreement between the EWGSOP2 and SDOC consensuses for sarcopenia in patients receiving hemodialysis: Findings of a cross sectional analysis from the SARC‐HD study
Background: Differences in definitions and operational diagnoses for sarcopenia create difficulties in understanding the epidemiology of the disease. We examined the prevalences of sarcopenia using the revised European Working Group on Sarcopenia in Older People (EWGSOP2) and the Sarcopenia Definitions and Outcomes Consortium (SDOC) consensuses and analyzed their level of agreement in patients receiving hemodialysis.Methods: Data from the SARCopenia trajectories and associations with clinical outcomes in patients receiving hemodialysis (SARC‐HD) multicenter study in Brazil were analyzed. Muscle strength was assessed using handgrip strength, muscle mass by calf circumference, and physical performance by the 4‐m gait speed test. Sarcopenia was diagnosed according to both the EWGSOP2 (low muscle strength plus low muscle mass) and the SDOC (low muscle strength plus low physical performance). The Cohen kappa statistic was used to determine the level of agreement between the consensuses.Results: 838 patients (57.8 ± 15.0 years; 61% men) from 19 dialysis units were included. We found similar prevalences of sarcopenia between the consensuses (EWGSOP2, n = 128, 15.3%; SDOC, n = 105, 12.5%) but with weak agreement (50 of 233 patients, 21.5%; κ = 0.34, 95% CI 0.25–0.43). Agreement was also weak within age categories (≥60 years, κ = 0.34; P < 0.001). Of the 51 patients diagnosed by the EWGSOP2 criterion as having severe sarcopenia, all but 1 (98.0%) met the SDOC criterion for sarcopenia (κ = 0.61, 95% CI 0.52–0.70). Low muscle strength was more frequently diagnosed using the SDOC than with the EWGSOP2 (52.3% vs 25.9%).Conclusion: We found a weak agreement between the EWGSOP2 and SDOC consensuses for the diagnosis of sarcopenia in patients receiving hemodialysis. Although still weak, agreement was marginally better for older patients. These findings highlight the importance of a global and standardized conceptual diagnosis of sarcopenia.